Ventilatory function and oxygen delivery at high altitude in the Himalayas
Respiratory Physiology & Neurobiology · 2023-08 · 314 · 104086
DOI: 10.1016/j.resp.2023.104086 ↗Kurz gefasst
Fachartikel in der Zeitschrift Respiratory Physiology & Neurobiology, 2023-08. Verfasst von Pierpaolo Prosperi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pneumology and Respiratory Physiopathology, S. Spirito Hospital, 66020 Pescara, Italy. Hauptthemen laut MEDLINE: Altitude, Altitude Sickness. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This study aimed to evaluate changes in lung function assessed by spirometry and blood gas content in healthy high-altitude sojourners during a trek in the Himalayas. A group of 19 Italian adults (11 males and 8 females, mean age 43 ± 15 years, and BMI 24.2 ± 3.7 kg/m2) were evaluated as part of a Mount Everest expedition in Nepal. Spirometry and arterial blood gas content were evaluated at baseline in Kathmandu (≈1400 m), at the Pyramid Laboratory - Observatory (peak altitude of ≈5000 m), and on return to Kathmandu 2-3 days after arrival at each site. All participants took 250 mg of acetazolamide per os once daily during the ascent. We found that arterial hemoglobin saturation, O2 and CO2 partial pressures, and the bicarbonate level all decreased (in all cases, p < 0.001 with R2 =0.70-0.90), while pHa was maintained stable at the peak altitude. Forced vital capacity (FVC) remained stable, while forced expiratory volume in 1 s (FEV1) decreased (p = 0.010, n2p =0.228), resulting in a lower FEV1/FVC ratio (p < 0.001, n2p =0.380). The best predictor for acute mountain sickness was the O2 partial pressure at the peak altitude (p = 0.004, R2 =0.39). Finger pulse oximetry overestimated peripheral saturation relative to arterial saturation. We conclude that high-altitude hypoxia alters the respiratory function and the oxygen saturation of the arterial blood hemoglobin. Additionally, air rarefaction and temperature reduction, favoring hypoxic bronchoconstriction, could affect respiration. Pulse oximetry seems not enough to assist medical decisions at high altitudes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pneumology and Respiratory Physiopathology, S. Spirito Hospital, 66020 Pescara, Italy.
- Department of Psychological, Health and Territorial Sciences, University "G. d'Annunzio" Chieti - Pescara, 66100 Chieti, Italy.
- Department of Translational Medicine and for Romagna, University of Ferrara, 44121 Ferrara, Italy.
- Department of Anesthesia, Critical Care, and Emergency, University of Turin, 10126 Turin, Italy.
- Department of Medicine and Aging Sciences, University "G. d'Annunzio" Chieti - Pescara, 66100 Chieti, Italy.
- Department of Neuroscience, Imaging and Clinical Sciences, University "G. d'Annunzio" Chieti - Pescara, 66100 Chieti, Italy. Electronic address: danilo.bondi@unich.it.
Zitieren
APA
Prosperi, P., Verratti, V., Taverna, A., Rua, R., Bonan, S., Rapacchiale, G., Bondi, D., Di Giulio, C., Lorkowski, J., & Spacone, A. (2023). Ventilatory function and oxygen delivery at high altitude in the Himalayas. Respiratory Physiology & Neurobiology, 314, 104086. https://doi.org/10.1016/j.resp.2023.104086
Vancouver
Prosperi P, Verratti V, Taverna A, Rua R, Bonan S, Rapacchiale G, et al. Ventilatory function and oxygen delivery at high altitude in the Himalayas. Respiratory Physiology & Neurobiology. 2023;314:104086. doi:10.1016/j.resp.2023.104086
BibTeX
@article{Prosperi2023,
author = {Prosperi, Pierpaolo and Verratti, Vittore and Taverna, Alberto and Rua, Riccardo and Bonan, Sofia and Rapacchiale, Giorgia and Bondi, Danilo and Di Giulio, Camillo and Lorkowski, Jacek and Spacone, Antonella},
title = {Ventilatory function and oxygen delivery at high altitude in the Himalayas},
journal = {Respiratory Physiology & Neurobiology},
year = {2023},
volume = {314},
pages = {104086},
doi = {10.1016/j.resp.2023.104086}
}
EUVIMED